3,5-bis-(3,4-dimethoxyphenylmethylene)piperidin-4-one | 886884-76-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3,5-bis-(3,4-dimethoxyphenylmethylene)piperidin-4-one
• 英文别名: 3,5-bis-(3,4-dimethoxybenzylidene)piperidin-4-one；3,5-bis[(3,4-dimethoxyphenyl)methylidene]piperidin-4-one
• CAS: 886884-76-0
• 化学式: C₂₃H₂₅NO₅
• 分子量: 395.455
• InChiKey: KNXCHAFCSTUPHS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.36
• 重原子数：
  29.0
• 可旋转键数：
  6.0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.26
• 拓扑面积：
  66.02
• 氢给体数：
  1.0
• 氢受体数：
  6.0

反应信息

• 作为反应物：
  描述：

  草酰氯 、 3,5-bis-(3,4-dimethoxyphenylmethylene)piperidin-4-one 在 三乙胺 作用下， 以 1,2-二氯乙烷 为溶剂， 以60%的产率得到1,2-bis[3,5-bis(3,4-dimethoxybenzylidene)-4-oxo-piperidin-1-yl]ethane-1,2-dione
  参考文献：
  名称：

  Novel 3,5-bis(arylidene)-4-piperidone dimers: Potent cytotoxins against colon cancer cells

  摘要：

  Two novel series of dimeric 3,5-bis(arylidene)-4-piperidones 7 and 8 were prepared as cytotoxic agents. A specific objective of this study was the discovery of novel compounds displaying potent anti-proliferative activities against colon cancers. Most of the compounds demonstrate potent cytotoxicity against HCT116 and HT29 colon cancer cell lines in which the IC50 values range from low micromolar to nanomolar values. In general, the majority of the compounds showed greater cytotoxicity and some degree of selectivity toward HCT116 cells compared to HT29 cells. Compound 9 in which the amidic carbonyl groups were excised was substantially less potent than 8a in both cell lines suggested that the amide groups are important components of the molecules for exhibiting cytotoxicity. Virtually all the compounds were more potent than a reference drug 5-fluorouracil which is used in treating colon cancers as well as a related enone curcumin. QSAR studies were undertaken and some guidelines for amplification of the project have been formulated. Flow cytometry analysis of a representative potent compound 7f revealed that it induces apoptosis in HCT116 cells. (C) 2013 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2013.03.055
• 作为产物：
  描述：

  4-哌啶酮 、 3,4-二甲氧基苯甲醛 在 盐酸 、 溶剂黄146 作用下， 反应 48.0h， 以51%的产率得到3,5-bis-(3,4-dimethoxyphenylmethylene)piperidin-4-one
  参考文献：
  名称：

  姜黄素类似物的高抗癌活性，低动物毒性和结构活性关系

  摘要：

  背景：抑制癌细胞生长和降低体内毒性是开发抗癌药物的两个重要标准。姜黄素是开发新型抗癌药物类似物的有希望的候选者。该研究小组设计了姜黄素的3,5-双-（3,4,5-三甲氧基亚苄基）-1-甲基-哌啶-4-一类似物，该类似物可显着抑制体内食管癌细胞的生长。在这项研究中，合成了81个姜黄素类似物，在体内外进行了分析，并确定了它们的结构活性关系（SAR）。 方法：根据姜黄素的母体结构，设计合成了3,5-双（取代亚苄基）-哌啶-4-酮化合物的81个类似物。使用MTT分析评估了它们在人类癌细胞系中的抗癌活性，并评估了小鼠体内毒性。分析了所选化合物的SAR。 结果与讨论：在设计的姜黄素类似物中，有61种化合物在体外具有比母体化合物更高的抗癌作用。23种化合物以低浓度（低于1μM的IC50值）抑制人癌细胞系中的细胞生长。在小鼠中测试了姜黄素类似物的急性毒性。选择了13种化合物，它们在高达25.0 mg /

  DOI：

  10.2174/2352096513999200714103641

文献信息

• Synthesis, Biological Evaluation and Molecular Docking Studies Against EGFR Tyrosine Kinase of 3,5-bis(substituted benzylidene)-1- ethylpiperidin-4-one Analogues
  作者：Mohamed Jawed Ahsan、Deepak Saini、Piush Sharma、Surender Singh Jadav、Mohammad Afroz Bakht、Salahuddin、Ramesh Alluri、Md Faiyazuddin

  DOI：10.2174/1570178617999201020220400

  日期：2021.7.29

  The compound 4g showed significant anticancer activity with GI₅₀ of 28.2 μM against MCF-7 (Breast cancer cell line). The antioxidant activity of compound 4g (IC₅₀ = 14.98±0.91 μM) was found to be comparable to the standard drug ascorbic acid. The binding modes of compounds 4a-g against the molecular target EGFR tyrosine kinase were also studied. The structure-activity relationship (SAR) was also studied.

  The compound 4g showed significant anticancer activity with GI₅₀ of 28.2 μM against MCF-7 (Breast cancer cell line). The antioxidant activity of the compound, 4g was found to be comparable to the standard drug ascorbic acid, while its anticancer activity was found to be less than that of the standard drug adriamycin.

  癌症是死亡的主要原因之一。本研究的目的是合成和研究一些3,5-双(取代苯甲醛基)-1-乙基哌啶-4-酮类似物(4a-g)的抗癌和抗氧化活性。 3,5-双(取代苯甲醛基)-1-乙基哌啶-4-酮类似物(4a-g)是从前体哌啶-4-酮盐酸盐(1)制备而来。首先合成中间体3,5-双(取代苯甲醛基)哌啶-4-酮类似物(3a-g)，然后在丙酮和K2CO3中与C2H5I进行乙基化反应，得到目标化合物(4a-g)。傅里叶变换红外(FTIR)、核磁共振(1H和13C NMR)、质谱和显微分析被用来表征目标化合物(4a-g)。所有化合物都通过SRB测定和NCI US方案进行了抗癌活性评估，通过DPPH自由基测定进行了抗氧化活性评估。所有目标化合物(4a-g)还被用于分子对接研究，以研究我们的化合物与分子靶点的可能相互作用方式。 化合物4g对MCF-7(乳腺癌细胞系)显示出显著的抗癌活性，GI50为28.2μM。化合物4g的抗氧化活性(IC50 = 14.98±0.91μM)与标准药物抗坏血酸相当。还研究了化合物4a-g与分子靶点EGFR酪氨酸激酶的结合模式，同时还研究了结构-活性关系(SAR)。 化合物4g对MCF-7(乳腺癌细胞系)显示出显著的抗癌活性，GI50为28.2μM。化合物4g的抗氧化活性与标准药物抗坏血酸相当，而其抗癌活性则低于标准药物阿霉素。
• Tumour-specific cytotoxicity and structure–activity relationships of novel 1-[3-(2-methoxyethylthio)propionyl]-3,5-bis(benzylidene)-4-piperidones
  作者：Mohammad Hossain、Umashankar Das、Naoki Umemura、Hiroshi Sakagami、Jan Balzarini、Erik De Clercq、Masami Kawase、Jonathan R. Dimmock

  DOI：10.1016/j.bmc.2016.03.056

  日期：2016.5

  piperidones 3-7 were designed and synthesized as novel cytotoxic agents. These compounds displayed potent cytotoxic properties towards human Molt4/C8, CEM, HSC-2, HSC-3 and HSC-4 neoplasms and also to murine L1210 cells. The majority of the compounds have sub-micromolar or very low micromolar IC50 and CC50 values and are significantly more potent than the reference alkylating drug melphalan. Evaluation

  设计并合成了一系列1-酰基-3,5-双（亚苄基）-4-哌啶酮3-7，作为新型细胞毒性剂。这些化合物对人Molt4 / C8，CEM，HSC-2，HSC-3和HSC-4肿瘤以及对鼠L1210细胞均显示出强大的细胞毒性。大多数化合物具有亚微摩尔或非常低的微摩尔IC50和CC50值，并且比参考烷基化药物美法仑显着更有效。这些化合物针对非恶性HGF和HPLF细胞的评估显示了肿瘤特异性毒性。特别地，3e作为有希望的铅细胞毒剂出现，它引起HSC-2细胞凋亡和PARP1裂解。